National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings, 67496-67497 [05-22075]
Download as PDF
<![CDATA[
67496
Federal Register / Vol. 70, No. 214 / Monday, November 7, 2005 / Notices
Dated: October 31, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–22072 Filed 11–4–05; 8:45am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meetings
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Board of Scientific Counselors, NIDA.
The meeting will be closed to the
public a indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute On Drug Abuse,
including consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, NIDA.
Date: November 28–30, 2005.
Time: 2 p.m. to 12 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: Intramural Research Program,
National Institute on Drug Abuse, NIH, Johns
Hopkins Bayview Campus, Bldg. C, 2nd
Floor Auditorium, Baltimore, MD 21224.
Contact Person: Stephen J. Heishman, PhD,
Research Psychologist, Clinical
Pharmacology Branch, Intramural Research
Program, National Institute on Drug Abuse,
National Institutes of Health, DHHS, 5500
Nathan Shock Drive, Baltimore, MD 21224,
(410) 550–1547.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 31, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–22073 Filed 11–4–05; 8:45 am]
BILLING CODE 4140–01–M
VerDate Aug<31>2005
16:38 Nov 04, 2005
Jkt 208001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Dental & Craniofacial Research Special
Emphasis Panel, 06–30, Review R03 & K’s.
Date: November 10, 2005.
Time: 2 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive. Bethesda,
MD 20892, (Telephone Conference Call).
Contact Person: Soheyla Saadi, PhD,
Scientific Review Administrator, Scientific
Review Branch, 45 Center Dr. Rm 4AN32A,
National Inst of Dental & Craniofacial
Research, National Institutes of Health,
Bethesda, MD 20892, (301) 594–4805,
saadisoh@nidcr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Dental & Craniofacial Research Special
Emphasis Panel, 06–22, Review R13.
Date: December 5, 2005.
Time: 10 a.m. to 11 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive. Bethesda,
MD 20892, (Telephone Conference Call).
Contact Person: Mary Kelly, Scientific
Review Specialist, National Institute of
Dental & Crainofacial Res., 45 Center Drive.
Bethesda, MD 20892–6402, (301) 594–4809,
Mary_Kelly@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
PO 00000
Frm 00087
Fmt 4703
Sfmt 4703
Dated: October 26, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–22074 Filed 11–4–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Mentored Research
Scientist Development Award (K01)
Application Review.
Date: November 21, 2005.
Time: 3 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Lakshmanan Sankaran,
PhD, Scientific Review Administrator,
Review Branch, DEA, NIDDK, National
Institutes of Health, Room 777, 6707
Democracy Boulevard, Bethesda, MD 20892–
5452, (301) 594–7799, ls38oz@nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Obesity Nutrition
Research Centers.
Date: November 29–30, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Double Tree Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Robert Wellner, PhD,
Scientific Review Administrator, Review
Branch, DEA, NIDDK, National Institutes Of
Health, Room 706, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–4721, rw175w@nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
E:\FR\FM\07NON1.SGM
07NON1
Federal Register / Vol. 70, No. 214 / Monday, November 7, 2005 / Notices
Special Emphasis Panel, Gene Therapy for
Pain.
Date: December 21, 2005.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Dan E. Matsumoto, PhD,
Scientific Review Administrator, Review
Branch, DEA, NIDDK, National Institutes Of
Health, Room 749, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–8894, matsumotod@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: October 26, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–22075 Filed 11–4–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commerical
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflicts: NSAA.
Date: November 17, 2005.
Time: 2:30 p.m. to 4 p.m.
Agenda: To review evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Valerie Durrant, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3148,
MSC 7770, Bethesda, MD 20892, (301) 435–
3554, durrant@csr.nih.gov.
VerDate Aug<31>2005
16:38 Nov 04, 2005
Jkt 208001
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflicts: NSCF.
Date: November 17, 2005.
Time: 4 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Valerie Durrant, PhD,
Scientific Review Administrator Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3148,
MSC 7770, Bethesda, MD 20892, (301) 435–
3554, durrant@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, ICI Member
Conflict.
Date: November 18, 2005.
Time: 2 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Marcia Steinberg, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5130,
MSC 7840, Bethesda, MD 20892, (301) 435–
1023, steinbem@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Bacterial
Molecular Genetics.
Date: November 18, 2005.
Time: 2:30 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Melody Mills, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3204,
MSC 7808, Bethesda, MD 20892, (301) 435–
0903, millsm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Review of
R21 and R15 Structure-Function
Applications.
Date: November 21, 2005.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Watergate, 2650 Virginia
Avenue, NW., Washington, DC 20037.
Contact Person: George W. Chacko, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4186,
MSC 7849, Bethesda, MD 20892, (301) 435–
1220, chackoge@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Cardiovascular Sciences BRP.
Date: November 21, 2005.
Time: 11 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Rajiv Kumar, PhD,
Scientific Review Administrator, Center for
PO 00000
Frm 00088
Fmt 4703
Sfmt 4703
67497
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4122,
MSC 7802, Bethesda, MD 20892, (301) 435–
1212, kumarra@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Biomolecular Recognition and Assembly
Program Project.
Date: November 22, 2005.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: David R. Jollie, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4156,
MSC 7806, Bethesda, MD 20892, (301) 435–
1722, jollieda@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Antibody
Tolerance and SLE.
Date: November 22, 2005.
Time: 10 a.m. to 11 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Jim Huang, PhD, Scientific
Review Administrator, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 4095G, MSC 7812,
Bethesda, MD 20892, (301) 435–1187,
jh377p@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Brain
Tumor Vaccine.
Date: November 22, 2005.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Angela Y. Ng, PhD, MBA,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6200,
MSC 7804, (For courier delivery, use MD
20817), Bethesda, MD 20892, 301–435–1715,
nga@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Imaging
Technology.
Date: November 22, 2005.
Time: 2 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Sally Ann Amero, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4190,
MSC 7849, Bethesda, MD 20892, 301–435–
1159, ameros@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Coagulation
Factor and Anticoagulant.
Date: November 22, 2005.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\07NON1.SGM
07NON1
]]>Agencies
[Federal Register Volume 70, Number 214 (Monday, November 7, 2005)]
[Notices]
[Pages 67496-67497]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-22075]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel, Mentored Research
Scientist Development Award (K01) Application Review.
Date: November 21, 2005.
Time: 3 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Lakshmanan Sankaran, PhD, Scientific Review
Administrator, Review Branch, DEA, NIDDK, National Institutes of
Health, Room 777, 6707 Democracy Boulevard, Bethesda, MD 20892-5452,
(301) 594-7799, ls38oz@nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel, Obesity Nutrition
Research Centers.
Date: November 29-30, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Double Tree Rockville, 1750 Rockville Pike, Rockville, MD
20852.
Contact Person: Robert Wellner, PhD, Scientific Review
Administrator, Review Branch, DEA, NIDDK, National Institutes Of
Health, Room 706, 6707 Democracy Boulevard, Bethesda, MD 20892-5452,
(301) 594-4721, rw175w@nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases
[[Page 67497]]
Special Emphasis Panel, Gene Therapy for Pain.
Date: December 21, 2005.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda,
MD 20892, (Telephone Conference Call).
Contact Person: Dan E. Matsumoto, PhD, Scientific Review
Administrator, Review Branch, DEA, NIDDK, National Institutes Of
Health, Room 749, 6707 Democracy Boulevard, Bethesda, MD 20892-5452,
(301) 594-8894, matsumotod@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: October 26, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-22075 Filed 11-4-05; 8:45 am]
BILLING CODE 4140-01-M
